Skip to main content

Table 5 Multivariate analysis

From: The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer

 

Time to progression

Variable

HR

95% CI

p value*

Age

1.521

1.105–2.093

0.010

Gender

1.313

0.939–1.837

0.111

Performance

2.079

0.743–5.816

0.163

Operation

1.143

0.763–1.713

0.516

Stage

0.941

0.763–1.161

0.571

Lauren type

1.035

0.857–1.250

0.720

Number of metastasis

1.375

1.129–1.674

0.002

−634 G/C polymorphism

1.497

1.074–2.088

0.017

  1. *by cox regression test.
  2. VEGF: vascular endothelial growth factor.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us